Document is current
Any future updates will be listed below
-
Authors
Shen, Xiuling
Zhou, Haoyi
Zhou, Xin
Liu, Zongchao https://orcid.org/0000-0002-2008-3793
Meng, Xiangxi https://orcid.org/0000-0002-6590-011X
Zhang, Linyu
Song, Yufei
Guo, Rui
Wang, Fei
Li, Kui
Li, Wenqing https://orcid.org/0000-0002-8336-5552
Yang, Zhi https://orcid.org/0000-0003-2084-5193
Liu, Zhaofei https://orcid.org/0000-0001-8718-8154
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81920108020 and 82325028)
Natural Science Foundation of Beijing Municipality (Z220011 and Z220014)
Beijing Nova Program (20220484182)
- License Information
-
More Information
Article History
Received: 2 July 2024
Accepted: 7 October 2024
First Online: 10 October 2024
Competing interests
: Z.-F.L. and H.Z. are inventors of a granted patent entitled “Granzyme B-targeting complex, radiopharmaceutical, preparation method therefor and use thereof” (patent number, ZL202111370138.7) related to <sup>68</sup>Ga-grazytracer described in this study. Other authors declare no potential conflicts of interest.
